Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

59.70
+0.11000.18%
Post-market: 59.62-0.0800-0.13%18:23 EDT
Volume:11.09M
Turnover:662.03M
Market Cap:121.53B
PE:13.14
High:60.10
Open:59.45
Low:59.01
Close:59.59
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.84
T/O Rate:0.55%
Dividend:2.51
Dividend Rate:4.20%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:5.45
PE(LYR):17.25

Loading ...

BMY Expands Real-World Cancer Data With New AUGTYRO Study in Korea

TIPRANKS
·
Oct 01

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 29

Helix BioPharma Names Karen Krumeich Board Chair, Adds Three Directors

Reuters
·
Sep 29

Bristol Myers Squibb Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 29

US Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 28

Bristol Myers Squibb Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 26

Bristol-Myers Squibb Says Zenbexus Combination Doubles MRD-Negative Complete Response in Multiple Myeloma Trial

MT Newswires Live
·
Sep 25

Bristol Myers reports results from prespecified analysis of EXCALIBER-RRMM trial

TIPRANKS
·
Sep 25

Bristol Myers Squibb Wins FDA Accelerated Approval for Zenbexus Combo in Multiple Myeloma

Reuters
·
Sep 25

Bristol Myers Squibb Announces First Presentation of Results for Zenbexus™ (Iberdomide) in Combination with Daratumumab from Phase 3 Excaliber-Rrmm Trial in Relapsed or Refractory Multiple Myeloma

THOMSON REUTERS
·
Sep 25

BMY’s Lung Cancer Combo Study Completion Adds Quiet Support to Its Immuno-Oncology Pipeline

TIPRANKS
·
Sep 25

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

RBC Capital Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY)

TIPRANKS
·
Sep 24

Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 24

Biokin Pharma Triggers Second $250 Million Milestone from Bristol Myers Squibb Deal; Shares Down 4%

MT Newswires Live
·
Sep 22

Travere Therapeutics Names Bradley Campbell CEO, Effective Dec. 1, 2026

Reuters
·
Sep 22

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 21

Sichuan Biokin Pharmaceutical Says Unit Received $250 Mln Milestone Payment from Bristol-Myers Squibb for Iza-Bren Agreement

THOMSON REUTERS
·
Sep 21

Bloomsbury Publishing (BMY) Gets a Buy from Berenberg Bank

TIPRANKS
·
Sep 18

Bristol Myers Squibb to Report Q3 Results, Host Earnings Call

Reuters
·
Sep 18